Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DRIVE: Remote Diabetes Intervention
NCT06046560Phase 4Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Mar 2021
- Primary completion
- Jul 2023
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Brigham and Women's Hospital. Primary endpoint: Number of Patients With Prescriptions of SGLT2i or GLP1-RA at Any Time at 6 months. Started Mar 2021; status: completed.
02
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT06046560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06046560.